CIRRHOTIC REGISTRY

  • What's involved: GS-US-337-1431: A Registry for Subjects with Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment with a Sofosbuvir-Based Regimen without Interferon for Chronic Hepatitis C Infection in Gilead-Sponsored Trials
  • Take part: Open
  • Principal Investigator: Professor Stephen Ryder
Research Theme | Gastrointestinal & Liver | Open Trials

A Registry for subjects with Cirrhosis who achieve a sustained virologic response following treatment with a Sofosbuvir-based regimen without Interferon for chronic Hepatitis C infection in Gilead-sponsored trials.

What's involved

GS-US-337-1431: A Registry for Subjects with Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment with a Sofosbuvir-Based Regimen without Interferon for Chronic Hepatitis C Infection in Gilead-Sponsored Trials

Principal Investigator

Professor Stephen Ryder

Take part

Open
Back to all trials

Contact Us

NIHR Biomedical Research Centre: Nottingham
Research & Innovation
D Floor (via South Block)
Nottingham University Hospitals NHS Trust
Queen’s Medical Centre
Derby Road
Nottingham
NG7 2UH

Telephone: 0115 924 9924

Director: Professor Ian Hall

Hosted by

Nottingham University Hospitals Logo

Nottingham University Hospitals Logo

We are a partnership between Nottingham University Hospitals NHS Trust and the University of Nottingham, supported by NHS and academic partners in Nottingham and across the East Midlands.

Website by Volute